North America Protein Expression Market Report and Forecast 2024-2032

North America Protein Expression Market Report and Forecast 2024-2032

North America Protein Expression Market Report and Forecast 2024-2032

North America Protein Expression Market Outlook

The North America protein expression market size was valued at USD 0.9 billion in 2023, driven by the increasing emphasis on developing effective therapeutics for treating chronic diseases in the region. The market is expected to grow at a CAGR of 8.20% during the forecast period of 2024-2032, with the values likely to rise from USD 1 billion in 2024 to USD 1.9 billion by 2032.

Key Takeaways

• 6 out of 10 Americans are affected by at least one chronic disease, according to the Centers for Disease Control and Prevention (CDC), which fuels the demand for protein-based therapeutics.
• Several key players are entering into strategic partnerships to create efficient protein expression systems. In July 2023 , Ginkgo Bioworks announced the completion of the pilot phase of their partnership with Novo Nordisk A/S to develop novel expression systems for pharmaceutical products.
• Advancements in protein expression technologies are attracting major investments from various sectors. In July 2023, Toronto based Liberum Biotech Inc ., secured USD 1.8 million in seed funding for its platform called “protein synthesis as a service”.

North America Protein Expression Market Analysis

Protein expression involves the synthesis, modification, and regulation of proteins in living organisms. The study of protein expression can help to determine the best treatment as well as its effectiveness in a patient. For instance, understanding protein expression in cancer cells can provide information about the cancer subtype, the optimal treatment plan, and its efficacy. The rising interest in personalized medicine is likely to propel the North America protein expression market growth in the coming years.

The market is witnessing increased demand for protein-based therapeutics, which can be attributed to the rise in the burden of chronic diseases in North America. According to the Centers for Disease Control and Prevention (CDC), 6 out of 10 Americans are affected by at least one chronic disease. These chronic diseases, including cancer, diabetes, and heart disease, are the leading drivers of death and disability in the region and are also responsible for substantial healthcare expenditure. The rising prevalence of chronic diseases is expected to directly augment the market demand as proteins are utilized in both the study as well as the treatment of such conditions.

The North America protein expression market demand is driven by the growing pipeline of biological medicines such as monoclonal antibodies, gene therapies, and vaccines. This expansion in the biologics market fuels the need for robust protein expression systems that are both flexible and efficient. To manufacture such complex expression systems, several key players are entering into partnerships to share resources and expertise. In July 2023 , Ginkgo Bioworks (a United States-based biotechnology company) announced the completion of the pilot phase of their partnership with Novo Nordisk A/S to develop novel expression systems for pharmaceutical products. Through collaborative efforts, the companies achieved their first milestone which included extensive modification and testing of a microbial expression system. The development of such engineered biological systems that can offer potential treatment options for patients with serious chronic diseases is anticipated to accelerate market growth.

One of the significant North America protein expression market trends is the increased advancements in protein expression technologies that allow scalable and cost-effective protein production and attract major investments from various sectors. In July 2023, Liberum Biotech Inc ., a Toronto-based startup, secured USD 1.8 million in seed funding for its platform “protein synthesis as a service” to support the development of its synthetic protein production technology. The company plans to use the funds to increase its production capacity and expand its portfolio of available proteins which also include the production of therapeutics and enzymes. The launch of innovative cell-free and cell-based platforms for protein synthesis is expected to bolster the market share in the forecast period.

North America Protein Expression Market Segmentation  

The report offers a detailed analysis of the market based on the following segments:

Market Breakup by Product

• Expression Vectors
• Competent Cells
• Reagents
• Instruments
• Services

Market Breakup by Application

• Industrial
• Research
• Therapeutic
• Others

Market Breakup by System Type

• Mammalian Cell Expression System
• Yeast Cell Expression System
• Insect Cell Expression System

Market Breakup by End User

• Academic Research
• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies
• Others

Market Breakup by Country

• United States
• Canada

North America Protein Expression Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Thermo Fisher Scientific Inc.
• GenScript Biotech Corporation
• Agilent Technologies Inc.
• Danaher Corporation
• Bio-Rad Laboratories Inc.
• Promega Corporation
• New England Biolabs
• Becton, Dickinson and Company
• Merck KGaA

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

FAQs

• What was the North America protein expression market value in 2023?

The market attained a value of about USD 0.9 billion in 2023 driven by the advancements in protein expression technologies in the region.

• What is the North America protein expression market forecast outlook for 2024-2032?

The market is anticipated to grow at a CAGR of 8.23% during the forecast period of 2024-2032, likely to reach a market value of USD 1.9 billion by 2032.

• What are the major factors aiding the North America protein expression market demand?

The growing prevalence of chronic diseases and the rising healthcare expenditure are fuelling the demand for the market.

• What are the major North America protein expression market trends?

One of the significant trends in the market is the increased strategic collaborations amongst the prominent market players. In July 2023, Ginkgo Bioworks (a United States-based biotechnology company) announced the completion of the pilot phase of their partnership with Novo Nordisk A/S to develop novel expression systems for pharmaceutical products.

• What is the market segmentation based on the product?

Based on the product, the market is segmented into expression vectors, competent cells, reagents, instruments, and services.

• What are the applications of the market?

Major applications of the market are industrial, research, and therapeutics among others.

• What is the market breakup by system type?

By system type, the market is divided into mammalian cell expression system, yeast cell expression system, insect cell expression system.

• What are the major end users of the market?

End users of the market are academic research, contract research organizations, and pharmaceutical and biotechnology companies among others.

• What is the market segmentation by countries?

The market segmentation by countries includes the United States of America and Canada.

• Who are the key players involved in the North America protein expression market?

The key players in the market are Thermo Fisher Scientific Inc., GenScript Biotech Corporation, Agilent Technologies Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Promega Corporation, New England Biolabs, Becton, Dickinson and Company, and Merck KGaA.

Meta description

The North America protein expression market size was valued at USD 0.9 billion in 2023 and it is anticipated to grow at a CAGR of 8.23% during the forecast period of 2024-2032.

*Please Note:* The report will take 7 business days to complete, after order confirmation.